Inventor · disambiguated record
Frank Pieper
Also filed as: PIEPER FRANK · PIEPER FRANK R · PIEPER FRANK ROBERT
16 granted patents·9 pending applications·2,205 citations·filing 1991–2015
96Inventor score
Files withPHARMING BV9PHARMING INTELLECTUAL PTY BV5LAB FRANCAIS DU FRACTIONNEMENT2MANNESSE MAURICE2BERKEL PATRICK V1
Top patents by PatentIndex Score
25 records- 0198US5741957ATransgenic bovinePHARMING BV·Filed 1995·Granted Apr 21, 1998·627 cites·36 claims
- 0298US5721367AHomologous recombination in mammalian cellsPHARMING BV·Filed 1995·Granted Feb 24, 1998·586 cites·23 claims
- 0396US5612205AHomologous recombination in mammalian cellsGENPHARM INT·Filed 1991·Granted Mar 18, 1997·540 cites·15 claims
- 0491US6118045ALysosomal proteins produced in the milk of transgenic animalsPHARMING BV·Filed 1996·Granted Sep 12, 2000·140 cites·20 claims
- 0590US8071532B2Use of C1 inhibitor for the prevention of ischemia-reperfusion injuryMANNESSE MAURICE·Filed 2006·Granted Dec 6, 2011·32 cites·22 claims
- 0690US5633076AMethod of producing a transgenic bovine or transgenic bovine embryoPHARMING BV·Filed 1993·Granted May 27, 1997·96 cites·29 claims
- 0789US8415288B2Use of C1 inhibitor for the prevention of ischemia-reperfusion injuryMANNESSE MAURICE·Filed 2011·Granted Apr 9, 2013·23 cites·13 claims
- 0882US6140552AProduction of recombinant polypeptides by bovine species and transgenic methodsPHARMING BV·Filed 1995·Granted Oct 31, 2000·36 cites·7 claims
- 0982US6066725AProduction of recombinant polypeptides by bovine species and transgenic methodsPHARMING BV·Filed 1998·Granted May 23, 2000·32 cites·1 claims
- 1080US8557773B2Treatment of bleeding with low half-life fibrinogenPIEPER FRANK·Filed 2009·Granted Oct 15, 2013·3 cites·14 claims
- 1180US7067713B2C1 Inhibitor produced in the milk of transgenic non-human mammalsPHARMING INTELLECTUAL PTY BV·Filed 2001·Granted Jun 27, 2006·23 cites·18 claims
- 1280US6013857ATransgenic bovines and milk from transgenic bovinesPHARMING BV·Filed 1995·Granted Jan 11, 2000·51 cites·22 claims
- 1379US9212215B2Treatment of bleeding with low half-life fibrinogenLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Dec 15, 2015·2 cites·14 claims
- 1462US9962431B2Treatment of bleeding with low half-life fibrinogenLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted May 8, 2018·0 cites·14 claims
- 1560US2003192068A1Production of recombinant polypeptides by bovine species and transgenic methodsPHARMING BV·Filed 2002·Application pending·0 cites
- 1659US2010305039A1Production of collagen in the milk of transgenic mammalsPHARMING INTELLECTUAL PTY BV·Filed 2008·Application pending·0 cites
- 1758US6713662B1Production of collagen in the milk of transgenic mammalsPHARMING INTELLECTUAL PTY BV·Filed 1995·Granted Mar 30, 2004·14 cites·26 claims
- 1855US9211318B2Use of C1 inhibitor for the prevention of ischemia-reperfusion injuryPHARMING INTELLECTUAL PTY BV·Filed 2013·Granted Dec 15, 2015·0 cites·26 claims
- 1955US2005198698A1Production of recombinant polypeptides by bovine species and transgenic methodsPHARMING B V A NETHERLANDS COR·Filed 2004·Application pending·0 cites
- 2051US2005172342A1Production of collagen in the milk of transgenic mammalsCOHESION TECH INC·Filed 2003·Application pending·0 cites
- 2148US2003097665A1Lysosomal proteins produced in the milk of transgenic animalsFiled 2000·Application pending·0 cites
- 2245US2004003421A1Lysosomal proteins produced in the milk of transgenic animalsPHARMING BV·Filed 2003·Application pending·0 cites
- 2344US2006142220A1Protein modificationBERKEL PATRICK V·Filed 2003·Application pending·0 cites
- 2444US2005223416A1C1 inhibitor produced in the milk of transgenic mammalsPHARMING INTELLECTUAL PTY BV·Filed 2005·Application pending·0 cites
- 2530US2007011754A1Lysosomal proteins produced in the milk of transgenic animalsREUSER ARNOLD J·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Pieper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →